Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0TI3R
|
|||
| Drug Name |
FLX-787
|
|||
| Indication | Amyotrophic lateral sclerosis [ICD-11: 8B60.0; ICD-9: 335.2] | Phase 2 | [1] | |
| Multiple sclerosis [ICD-11: 8A40; ICD-9: 340] | Phase 2 | [2] | ||
| Muscle spasm [ICD-11: MB47.3; ICD-10: R25.2] | Phase 2 | [1] | ||
| Company |
Flex Pharma, Boston, MA
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Melanoma antigen gp75 (TYRP1) | Target Info | Activator | [2] |
| Transient receptor potential channel (TRP channel) | Target Info | Agonist | [1] | |
| BioCyc | Eumelanin biosynthesis | |||
| KEGG Pathway | Tyrosine metabolism | |||
| Metabolic pathways | ||||
| Melanogenesis | ||||
| Pathwhiz Pathway | Degradation of Superoxides | |||
| Pathway Interaction Database | Direct p53 effectors | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.